Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2026-02-01 @ 9:37 AM
Study NCT ID:
NCT03636503
Status:
TERMINATED
Last Update Posted:
2025-02-06
First Post:
2018-08-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab + Immunotherapy in Follicular Lymphoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-02
First Submit QC Date:
None
Study First Post Date:
2018-08-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-20
Results First Submit QC Date:
None
Results First Post Date:
2025-02-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-13
Last Update Post Date:
2025-02-06
Last Update Post Date Type:
ACTUAL